|
PCNA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.56940005014673E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.61870000000253E-05 |
| Normal-vs-Stage2 |
2.518400E-02 |
| Normal-vs-Stage3 |
3.769100E-04 |
| Normal-vs-Stage4 |
2.323600E-02 |
| Stage1-vs-Stage2 |
7.572600E-01 |
| Stage1-vs-Stage3 |
2.154300E-02 |
| Stage1-vs-Stage4 |
7.710800E-01 |
| Stage2-vs-Stage3 |
7.446200E-02 |
| Stage2-vs-Stage4 |
9.563000E-01 |
| Stage3-vs-Stage4 |
7.856200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56010000029738E-07 |
| Normal-vs-AfricanAmerican |
1.005730E-04 |
| Normal-vs-Asian |
6.45910000000027E-05 |
| Caucasian-vs-AfricanAmerican |
7.675600E-01 |
| Caucasian-vs-Asian |
4.978600E-01 |
| AfricanAmerican-vs-Asian |
3.393200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63239999999565E-05 |
| Normal-vs-Female |
4.11699996316628E-09 |
| Male-vs-Female |
7.374400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.683800E-03 |
| Normal-vs-Extreme_Weight |
6.234500E-04 |
| Normal-vs-Obese |
1.8173099999963E-05 |
| Normal-vs-Extreme_Obese |
7.479400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.823800E-01 |
| Normal_Weight-vs-Obese |
2.281000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.222000E-01 |
| Extreme_Weight-vs-Obese |
4.864000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.626600E-01 |
| Obese-vs-Extreme_Obese |
8.976200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.256900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.18299999585636E-08 |
| Normal-vs-Age(61-80Yrs) |
5.91859999999889E-05 |
| Normal-vs-Age(81-100Yrs) |
3.028800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.904010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.411700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.054190E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.410500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.564300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.824400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.52660000050243E-07 |
| Normal-VS-Type2 PRCC |
1.264350E-02 |
| Normal-VS-KIRP CIMP |
3.277300E-03 |
| Normal-VS-Unclassified PRCC |
4.001100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.994030E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.438140E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.553600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.517800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.096100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.789800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.003890E-02 |
| Normal-vs-N1 |
5.800100E-04 |
| Normal-vs-N2 |
5.248800E-01 |
| N0-vs-N1 |
1.739560E-02 |
| N0-vs-N2 |
8.676000E-01 |
| N1-vs-N2 |
3.549000E-01 |
|
|
